You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 118 No. 4, April 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Laboratory Sciences
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (20)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Ophthalmology, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Elevated Glutamate Levels in the Vitreous Body of an In Vivo Model of Optic Nerve Ischemia

Tae Woo Kim, MD; Kyung Bok Kang, MD; Ho-Kyung Choung, MD; Ki Ho Park, MD; Dong Myung Kim, MD

Arch Ophthalmol. 2000;118:533-536.

Objective  To explore the possibility that an elevation of glutamate levels in the vitreous might be associated with the microvascular compromise of the optic nerve.

Materials and Methods  Endothelin-1, 0.1 µg/d (5 rabbits), or balanced salt solution (4 rabbits) was delivered to the perineural region of the anterior optic nerve by osmotically driven minipumps for 2 weeks. Vitreous specimens were obtained, and their amino acid contents were determined by high-performance liquid chromatography.

Results  There was a statistically significant elevation in the mean ± SEM vitreous concentrations of glutamate (264% ± 41%; P=.04), aspartate (269% ± 31%; P=.04), and glycine (232% ± 26%; P=.04) in the eyes subjected to endothelin-1 when compared with the fellow control eyes.

Conclusion  Administration of endothelin-1 to the microvasculature of the optic nerve leads to elevation of glutamate, aspartate, and glycine concentrations in the vitreous.

Clinical Relevance  The increase of excitatory amino acids in the vitreous might be associated with various ischemic processes of the optic nerve, including glaucomatous optic neuropathy, and may play a role in the neuronal damage that is seen in these diseases.


From the Department of Ophthalmology, Seoul National University Hospital, Seoul, Korea.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Plasminogen activators promote excitotoxicity-induced retinal damage
Mali et al.
FASEB J. 2005;19:1280-1289.
ABSTRACT | FULL TEXT  

Retinal Glutamate Transporter Changes in Experimental Glaucoma and after Optic Nerve Transection in The Rat
Martin et al.
IOVS 2002;43:2236-2243.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.